NASDAQ

Agios Reports Second Quarter 2016 Financial Results

- Data from PKR Activators at EHA Demonstrated Proof-of-Concept for AG-348 and Proof-of-Mechanism for ...

Curis Reports Second Quarter 2016 Financial Results

LEXINGTON, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

Clearside Biomedical, Inc. to Report Second Quarter 2016 Financial Results

ALPHARETTA, Ga., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage ...

Radius Health Reports Second Quarter 2016 Financial and Operating Results

Radius’ NDA for abaloparatide-SC for the treatment of postmenopausal women with osteoporosis was accepted ...

Anthera Pharmaceuticals Announces Completion of Dosing in CHABLIS-SC1 Phase 3 Clinical Study with Blisibimod

HAYWARD, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced that ...

Anthera Pharmaceuticals Announces Completion of Dosing in CHABLIS-SC1 Phase 3 Clinical Study with Blisibimod

HAYWARD, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced that ...

Myriad Genetics Signs Definitive Agreement to Acquire Assurex Health

SALT LAKE CITY, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a ...

Myriad Genetics Signs Definitive Agreement to Acquire Assurex Health

SALT LAKE CITY, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a ...

XOMA Reports Second Quarter 2016 Achievements and Financial Results

BERKELEY, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in ...

XOMA Reports Second Quarter 2016 Achievements and Financial Results

BERKELEY, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in ...